BioTuesdays

Category - Executive Moves

XORTX Therapeutics

XORTX Therapeutics names Dave Matthews as CFO

XORTX Therapeutics (CSE:XRX) recently announced the appointment of Dave Matthews as CFO, replacing John Meekison, who acted as interim CFO for XORTX since the company’s founding. Mr. Meekison will remain with XORTX to...

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.